Stay updated on GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.
Latest updates to the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page
- Check6 days agoChange DetectedNo significant additions or deletions detected; the page content and study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check13 days agoChange DetectedThe update appears to involve minor user-interface adjustments and a timestamp change on the Study Details page; there are no changes to core study content such as eligibility criteria, outcomes, or study design. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check20 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; no changes to study content, eligibility criteria, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check28 days agoChange DetectedRemoved the general notice about government funding and NIH operating status from the ClinicalTrials.gov page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check42 days agoChange DetectedNo significant changes detected to the Study Details page; core information such as eligibility, locations, and outcomes appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check49 days agoChange DetectedThe page shows the same study details with the last update date updated to 2025-08-26; no additions or deletions to the study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
Stay in the know with updates to GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.